{"transactions":[{"id":2749660,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":140282,"kind":"person","name":"Barone Samuel B.","position":1,"cik":"0001614995","reported_name":"Barone Samuel B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-14T20:03:03.000Z","date":"2021-04-12","kind":"grant","acquired":true,"shares":255212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over a period of four years from the Vesting Start Date, April 12, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company."}],"balance_after":255212,"derivative":{"exercise_price":12.59,"expiration_date":"2031-04-11","underlying":"Common Stock","underlying_shares":255212},"source":{"system":"sec-edgar","filing":"0001213900-21-021520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000121390021021520/ownership.xml","form_type":"4"}},{"id":4453429,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":140282,"kind":"person","name":"Barone Samuel B.","position":1,"cik":"0001614995","reported_name":"Barone Samuel B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-13T17:35:56.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":84000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of the Vesting Commencement Date, and 1/48th of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":84000,"derivative":{"exercise_price":2.7,"expiration_date":"2027-02-08","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0001209191-17-010103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501756/000120919117010103/doc4.xml","form_type":"4"}},{"id":4453428,"issuer":{"id":71889,"kind":"organization","name":"Adverum Biotechnologies, Inc.","symbol":"ADVM"},"owners":[{"id":140282,"kind":"person","name":"Barone Samuel B.","position":1,"cik":"0001614995","reported_name":"Barone Samuel B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Development"}}],"security":"Common Stock","published_at":"2017-02-13T17:35:56.000Z","date":"2017-02-09","kind":"grant","acquired":true,"shares":58000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of Common Stock of the Issuer for each one (1) RSU upon the vesting thereof. Such RSUs vest with respect to 25% of the shares subject thereto on each anniversary of February 9, 2017 (the \"Vesting Commencement Date\"), such that all of the shares subject to the RSUs shall be vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":172335,"source":{"system":"sec-edgar","filing":"0001209191-17-010103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501756/000120919117010103/doc4.xml","form_type":"4"}}]}